A citation-based method for searching scientific literature

Shereef Elsamany, Sakher Abdullah. Med Oncol 2014
Times Cited: 23







List of co-cited articles
65 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
Brian D Lehmann, Joshua A Bauer, Xi Chen, Melinda E Sanders, A Bapsi Chakravarthy, Yu Shyr, Jennifer A Pietenpol. J Clin Invest 2011
39

Triple-negative breast carcinoma: current and emerging concepts.
Robert Schmadeka, Bryan E Harmon, Meenakshi Singh. Am J Clin Pathol 2014
113
30


Triple-negative breast cancer.
William D Foulkes, Ian E Smith, Jorge S Reis-Filho. N Engl J Med 2010
17

Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer.
Matthew D Burstein, Anna Tsimelzon, Graham M Poage, Kyle R Covington, Alejandro Contreras, Suzanne A W Fuqua, Michelle I Savage, C Kent Osborne, Susan G Hilsenbeck, Jenny C Chang,[...]. Clin Cancer Res 2015
666
17

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies.
Fiona M Blows, Kristy E Driver, Marjanka K Schmidt, Annegien Broeks, Flora E van Leeuwen, Jelle Wesseling, Maggie C Cheang, Karen Gelmon, Torsten O Nielsen, Carl Blomqvist,[...]. PLoS Med 2010
618
13

Heterogeneity in breast cancer.
Kornelia Polyak. J Clin Invest 2011
551
13

Dissecting the heterogeneity of triple-negative breast cancer.
Otto Metzger-Filho, Andrew Tutt, Evandro de Azambuja, Kamal S Saini, Giuseppe Viale, Sherene Loi, Ian Bradbury, Judith M Bliss, Hatem A Azim, Paul Ellis,[...]. J Clin Oncol 2012
299
8

Understanding the biology of triple-negative breast cancer.
C Criscitiello, H A Azim, P C Schouten, S C Linn, C Sotiriou. Ann Oncol 2012
107
8



Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experience.
L Staudacher, P H Cottu, V Diéras, A Vincent-Salomon, M N Guilhaume, L Escalup, T Dorval, P Beuzeboc, L Mignot, J Y Pierga. Ann Oncol 2011
66
8

Hallmarks of 'BRCAness' in sporadic cancers.
Nicholas Turner, Andrew Tutt, Alan Ashworth. Nat Rev Cancer 2004
8



Novel strategies towards the use of anti-angiogenic agents in breast cancer.
Janine L Bakker, Hanne Meijers-Heijboer, Henk Verheul. Eur J Pharmacol 2013
4
50


Vagotomy enhances experimental metastases of 4THMpc breast cancer cells and alters substance P level.
Nuray Erin, Güliz Akdas Barkan, John F Harms, Gary A Clawson. Regul Pept 2008
54
8

Differential characteristics of heart, liver, and brain metastatic subsets of murine breast carcinoma.
Nuray Erin, Sule Kale, Gamze Tanrıöver, Sadi Köksoy, Ozlem Duymuş, Aylin F Korcum. Breast Cancer Res Treat 2013
34
8

Capsaicin-mediated denervation of sensory neurons promotes mammary tumor metastasis to lung and heart.
Nuray Erin, Philip J Boyer, Robert H Bonneau, Gary A Clawson, Danny R Welch. Anticancer Res 2004
69
8

Activation of vagus nerve by semapimod alters substance P levels and decreases breast cancer metastasis.
Nuray Erin, Ozlem Duymuş, Saffet Oztürk, Necdet Demir. Regul Pept 2012
37
8



Standard treatments induce antigen-specific immune responses in prostate cancer.
Nancy J Nesslinger, Robert A Sahota, Brad Stone, Kayli Johnson, Navraj Chima, Caitlin King, Devon Rasmussen, Darcy Bishop, Paul S Rennie, Martin Gleave,[...]. Clin Cancer Res 2007
125
8

Capsaicin-induced inactivation of sensory neurons promotes a more aggressive gene expression phenotype in breast cancer cells.
Nuray Erin, Wei Zhao, John Bylander, Gary Chase, Gary Clawson. Breast Cancer Res Treat 2006
63
8

Neurokinin-1 receptor agonists bias therapeutic dendritic cells to induce type 1 immunity by licensing host dendritic cells to produce IL-12.
Brian M Janelsins, Tina L Sumpter, Olga A Tkacheva, Darling M Rojas-Canales, Geza Erdos, Alicia R Mathers, William J Shufesky, Walter J Storkus, Louis D Falo, Adrian E Morelli,[...]. Blood 2013
39
8

Triple-negative breast cancer and the need for new therapeutic targets.
Olav Engebraaten, Hans Kristian Moen Vollan, Anne-Lise Børresen-Dale. Am J Pathol 2013
105
8

Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor status.
Hee Jeong Kim, Mi-Jung Kim, Sei Hyun Ahn, Byung Ho Son, Sung Bae Kim, Jin Hee Ahn, Woo Chul Noh, Gyungyub Gong. Breast 2011
52
8

Molecular characterization of basal-like and non-basal-like triple-negative breast cancer.
Aleix Prat, Barbara Adamo, Maggie C U Cheang, Carey K Anders, Lisa A Carey, Charles M Perou. Oncologist 2013
355
8

CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
Michael O Idowu, Maciej Kmieciak, Catherine Dumur, Regina S Burton, Margaret M Grimes, Celeste N Powers, Masoud H Manjili. Hum Pathol 2012
174
8

The CD44+/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients.
Alexandra Giatromanolaki, Efthimios Sivridis, Aliki Fiska, Michael I Koukourakis. Med Oncol 2011
92
8

Obesity, type 2 diabetes, and cancer: the insulin and IGF connection.
Dara Hope Cohen, Derek LeRoith. Endocr Relat Cancer 2012
186
8

Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation.
Jessica L Harding, Jonathan E Shaw, Anna Peeters, Bendix Cartensen, Dianna J Magliano. Diabetes Care 2015
148
8

Biomarkers in triple negative breast cancer: A review.
Budhi S Yadav, Priyanka Chanana, Swaty Jhamb. World J Clin Oncol 2015
68
8

Triple-negative breast cancer: clinical features and patterns of recurrence.
Rebecca Dent, Maureen Trudeau, Kathleen I Pritchard, Wedad M Hanna, Harriet K Kahn, Carol A Sawka, Lavina A Lickley, Ellen Rawlinson, Ping Sun, Steven A Narod. Clin Cancer Res 2007
8


Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design.
Farrah Kassam, Katherine Enright, Rebecca Dent, George Dranitsaris, Jeff Myers, Candi Flynn, Michael Fralick, Ritu Kumar, Mark Clemons. Clin Breast Cancer 2009
292
8

Androgen receptor expression predicts decreased survival in early stage triple-negative breast cancer.
Jung Eun Choi, Su Hwan Kang, Soo Jung Lee, Young Kyung Bae. Ann Surg Oncol 2015
88
8

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.
Balazs Györffy, Andras Lanczky, Aron C Eklund, Carsten Denkert, Jan Budczies, Qiyuan Li, Zoltan Szallasi. Breast Cancer Res Treat 2010
8



Triple-negative breast cancer: present challenges and new perspectives.
Franca Podo, Lutgarde M C Buydens, Hadassa Degani, Riet Hilhorst, Edda Klipp, Ingrid S Gribbestad, Sabine Van Huffel, Hanneke W M van Laarhoven, Jan Luts, Daniel Monleon,[...]. Mol Oncol 2010
206
8

Prospective identification of tumorigenic breast cancer cells.
Muhammad Al-Hajj, Max S Wicha, Adalberto Benito-Hernandez, Sean J Morrison, Michael F Clarke. Proc Natl Acad Sci U S A 2003
8

Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC).
Eun Yoon Cho, Myung Hee Chang, Yoon La Choi, Jeong Eon Lee, Seok Jin Nam, Jung-Hyun Yang, Yeon Hee Park, Jin Seok Ahn, Young-Hyuck Im. Cancer Chemother Pharmacol 2011
21
9

Targeting triple-negative breast cancer: optimising therapeutic outcomes.
K Gelmon, R Dent, J R Mackey, K Laing, D McLeod, S Verma. Ann Oncol 2012
125
8


Multidisciplinary cancer care: does it improve outcomes?
Savtaj S Brar, Nicole Look Hong, Frances C Wright. J Surg Oncol 2014
48
8


Cancer multidisciplinary team meetings: evidence, challenges, and the role of clinical decision support technology.
Vivek Patkar, Dionisio Acosta, Tim Davidson, Alison Jones, John Fox, Mohammad Keshtgar. Int J Breast Cancer 2011
89
8

Quality improvement by implementing an integrated oncological care pathway for breast cancer patients.
J van Hoeve, L de Munck, R Otter, J de Vries, S Siesling. Breast 2014
33
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.